1.
Martínez SN, Ramos R, Navarro-Perez J, Lopez MJ, Vazquez M del M, Molto J, et al. Safety and Immunogenicity of a PHH-1V Booster Dose after Different Prime Vaccination Schemes against Covid-19: Phase III Clinical Trial Final Results Up To One Year. acbr [Internet]. 2024 Aug. 6 [cited 2026 Jun. 6];8(4):326-42. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/15082